DOI QR코드

DOI QR Code

Metabolic Risk Profile and Cancer in Korean Men and Women

  • Ko, Seulki (Department of Preventive Medicine, Korea University College of Medicine) ;
  • Yoon, Seok-Jun (Department of Preventive Medicine, Korea University College of Medicine) ;
  • Kim, Dongwoo (Department of Preventive Medicine, Korea University College of Medicine) ;
  • Kim, A-Rim (Department of Public Health, Graduate School of Korea University) ;
  • Kim, Eun-Jung (Department of Economics, Economic Research Institute, Korea University) ;
  • Seo, Hye-Young (Department of Public Health, Graduate School of Korea University)
  • Received : 2016.02.22
  • Accepted : 2016.04.05
  • Published : 2016.05.31

Abstract

Objectives: Metabolic syndrome is a cluster of risk factors for type 2 diabetes mellitus and cardiovascular disease. Associations between metabolic syndrome and several types of cancer have recently been documented. Methods: We analyzed the sample cohort data from the Korean National Health Insurance Service from 2002, with a follow-up period extending to 2013. The cohort data included 99 565 individuals who participated in the health examination program and whose data were therefore present in the cohort database. The metabolic risk profile of each participant was assessed based on obesity, high serum glucose and total cholesterol levels, and high blood pressure. The occurrence of cancer was identified using Korean National Health Insurance claims data. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using Cox proportional hazards models, adjusting for age group, smoking status, alcohol intake, and regular exercise. Results: A total of 5937 cases of cancer occurred during a mean follow-up period of 10.4 years. In men with a high-risk metabolic profile, the risk of colon cancer was elevated (HR, 1.40; 95% CI, 1.14 to 1.71). In women, a high-risk metabolic profile was associated with a significantly increased risk of gallbladder and biliary tract cancer (HR, 2.05; 95% CI, 1.24 to 3.42). Non-significantly increased risks were observed in men for pharynx, larynx, rectum, and kidney cancer, and in women for colon, liver, breast, and ovarian cancer. Conclusions: The findings of this study support the previously suggested association between metabolic syndrome and the risk of several cancers. A high-risk metabolic profile may be an important risk factor for colon cancer in Korean men and gallbladder and biliary tract cancer in Korean women.

Keywords

References

  1. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15(7):539-553. https://doi.org/10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
  2. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120(16):1640-1645. https://doi.org/10.1161/CIRCULATIONAHA.109.192644
  3. Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, et al. The metabolic syndrome. Endocr Rev 2008;29 (7):777-822. https://doi.org/10.1210/er.2008-0024
  4. Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am 2004;33(2):351-375. https://doi.org/10.1016/j.ecl.2004.03.005
  5. Kassi E, Pervanidou P, Kaltsas G, Chrousos G. Metabolic syndrome: definitions and controversies. BMC Med 2011;9:48. https://doi.org/10.1186/1741-7015-9-48
  6. Mozumdar A, Liguori G. Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999-2006. Diabetes Care 2011;34(1):216-219. https://doi.org/10.2337/dc10-0879
  7. Lim S, Shin H, Song JH, Kwak SH, Kang SM, Yoon JW, et al. Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998-2007. Diabetes Care 2011;34(6):1323-1328. https://doi.org/10.2337/dc10-2109
  8. Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab 2008;93(11 Suppl 1):S9-S30. https://doi.org/10.1210/jc.2008-1595
  9. Esposito K, Chiodini P, Colao A, Lenzi A, Giugliano D. Metabolic syndrome and risk of cancer: a systematic review and metaanalysis. Diabetes Care 2012;35(11):2402-2411. https://doi.org/10.2337/dc12-0336
  10. Stocks T, Bjorge T, Ulmer H, Manjer J, Haggstrom C, Nagel G, et al. Metabolic risk score and cancer risk: pooled analysis of seven cohorts. Int J Epidemiol 2015;44(4):1353-1363. https://doi.org/10.1093/ije/dyv001
  11. Jinjuvadia R, Patel S, Liangpunsakul S. The association between metabolic syndrome and hepatocellular carcinoma: systemic review and meta-analysis. J Clin Gastroenterol 2014; 48(2):172-177. https://doi.org/10.1097/MCG.0b013e3182a030c4
  12. Esposito K, Chiodini P, Capuano A, Bellastella G, Maiorino MI, Rafaniello C, et al. Colorectal cancer association with metabolic syndrome and its components: a systematic review with meta-analysis. Endocrine 2013;44(3):634-647. https://doi.org/10.1007/s12020-013-9939-5
  13. Bjorge T, Lukanova A, Jonsson H, Tretli S, Ulmer H, Manjer J, et al. Metabolic syndrome and breast cancer in the Me-Can (metabolic syndrome and cancer) project. Cancer Epidemiol Biomarkers Prev 2010;19(7):1737-1745. https://doi.org/10.1158/1055-9965.EPI-10-0230
  14. Osaki Y, Taniguchi S, Tahara A, Okamoto M, Kishimoto T. Metabolic syndrome and incidence of liver and breast cancers in Japan. Cancer Epidemiol 2012;36(2):141-147. https://doi.org/10.1016/j.canep.2011.03.007
  15. Shebl FM, Andreotti G, Meyer TE, Gao YT, Rashid A, Yu K, et al. Metabolic syndrome and insulin resistance in relation to biliary tract cancer and stone risks: a population-based study in Shanghai, China. Br J Cancer 2011;105(9):1424-1429. https://doi.org/10.1038/bjc.2011.363
  16. Jee SH, Yun JE, Park EJ, Cho ER, Park IS, Sull JW, et al. Body mass index and cancer risk in Korean men and women. Int J Cancer 2008;123(8):1892-1896. https://doi.org/10.1002/ijc.23719
  17. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM. Fasting serum glucose level and cancer risk in Korean men and women. JAMA 2005;293(2):194-202. https://doi.org/10.1001/jama.293.2.194
  18. Kitahara CM, Berrington de Gonzalez A, Freedman ND, Huxley R, Mok Y, Jee SH, et al. Total cholesterol and cancer risk in a large prospective study in Korea. J Clin Oncol 2011;29(12): 1592-1598. https://doi.org/10.1200/JCO.2010.31.5200
  19. Lee JS, Cho SI, Park HS. Metabolic syndrome and cancer-related mortality among Korean men and women. Ann Oncol 2010;21(3):640-645. https://doi.org/10.1093/annonc/mdp344
  20. Lee J, Lee JS, Park SH, Shin SA, Kim K. Cohort profile: the National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea. Int J Epidemiol 2016. doi: http://dx. doi.org/10.1093/ije/dyv319.
  21. World Health Organization Western Pacific Region. The Asian- Pacific perspective: redefining obesity and its treatment; 2000 [cited 2016 May 11]. Available from: http://www.wpro.who.int/nutrition/documents/docs/Redefiningobesity.pdf.
  22. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26(11):3160-3167. https://doi.org/10.2337/diacare.26.11.3160
  23. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106(25):3143-3421.
  24. Borena W, Edlinger M, Bjorge T, Haggstrom C, Lindkvist B, Nagel G, et al. A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (Me-Can) collaborative study. PLoS One 2014;9(2):e89368. https://doi.org/10.1371/journal.pone.0089368
  25. Kim BC, Shin A, Hong CW, Sohn DK, Han KS, Ryu KH, et al. Association of colorectal adenoma with components of metabolic syndrome. Cancer Causes Control 2012;23(5):727-735. https://doi.org/10.1007/s10552-012-9942-9
  26. Lee GE, Park HS, Yun KE, Jun SH, Kim HK, Cho SI, et al. Association between BMI and metabolic syndrome and adenomatous colonic polyps in Korean men. Obesity (Silver Spring) 2008;16(6):1434-1439. https://doi.org/10.1038/oby.2008.216
  27. Esposito K, Chiodini P, Capuano A, Bellastella G, Maiorino MI, Rafaniello C, et al. Metabolic syndrome and postmenopausal breast cancer: systematic review and meta-analysis. Menopause 2013;20(12):1301-1309. https://doi.org/10.1097/GME.0b013e31828ce95d
  28. Agnoli C, Grioni S, Sieri S, Sacerdote C, Ricceri F, Tumino R, et al. Metabolic syndrome and breast cancer risk: a case-cohort study nested in a multicentre Italian cohort. PLoS One 2015; 10(6):e0128891. https://doi.org/10.1371/journal.pone.0128891
  29. Mendonca FM, de Sousa FR, Barbosa AL, Martins SC, Araujo RL, Soares R, et al. Metabolic syndrome and risk of cancer: which link? Metabolism 2015;64(2):182-189. https://doi.org/10.1016/j.metabol.2014.10.008
  30. Giovannucci E. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr 2007;86(3):s836-s842. https://doi.org/10.1093/ajcn/86.3.836S
  31. Wang YY, Lin SY, Lai WA, Liu PH, Sheu WH. Association between adenomas of rectosigmoid colon and metabolic syndrome features in a Chinese population. J Gastroenterol Hepatol 2005;20(9):1410-1415. https://doi.org/10.1111/j.1440-1746.2005.03971.x
  32. Chen LY, Qiao QH, Zhang SC, Chen YH, Chao GQ, Fang LZ. Metabolic syndrome and gallstone disease. World J Gastroenterol 2012;18(31):4215-4220. https://doi.org/10.3748/wjg.v18.i31.4215
  33. Stocks T, Borena W, Strohmaier S, Bjorge T, Manjer J, Engeland A, et al. Cohort profile: the metabolic syndrome and cancer project (Me-Can). Int J Epidemiol 2010;39(3):660-667. https://doi.org/10.1093/ije/dyp186
  34. Song SO, Jung CH, Song YD, Park CY, Kwon HS, Cha BS, et al. Background and data configuration process of a nationwide population-based study using the Korean National Health Insurance System. Diabetes Metab J 2014;38(5):395-403. https://doi.org/10.4093/dmj.2014.38.5.395
  35. Jung KW, Won YJ, Kong HJ, Oh CM, Cho H, Lee DH, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat 2015;47(2):127-141. https://doi.org/10.4143/crt.2015.060
  36. Seo HJ, Oh IH, Yoon SJ. A comparison of the cancer incidence rates between the national cancer registry and insurance claims data in Korea. Asian Pac J Cancer Prev 2012;13(12): 6163-6168. https://doi.org/10.7314/APJCP.2012.13.12.6163
  37. National Health Insurance Data Sharing Service. DB detail and payment of fee [cited 2016 Mar 21]. Available from: https://nhiss.nhis.or.kr/bd/ab/bdaba006cv.do# (Korean).

Cited by

  1. A Case of Endoscopic Submucosal Dissection of Esophageal Adenocarcinoma Arising from Barrett's Esophagus vol.16, pp.3, 2016, https://doi.org/10.7704/kjhugr.2016.16.3.169
  2. Impact of diabetes mellitus on the risk and survival of nasopharyngeal carcinoma: a meta-analysis vol.11, pp.None, 2016, https://doi.org/10.2147/ott.s152217
  3. Metabolic syndrome and the incidence of hepatocellular carcinoma: a meta-analysis of cohort studies vol.11, pp.None, 2016, https://doi.org/10.2147/ott.s154848
  4. Effect of Work-Related Sedentary Time on Overall Health Profile in Active vs. Inactive Office Workers vol.6, pp.None, 2016, https://doi.org/10.3389/fpubh.2018.00279
  5. Incidence and risk factors of colorectal cancer based on 56 324 health checkups: A 7‐year retrospective cohort study vol.33, pp.4, 2018, https://doi.org/10.1111/jgh.14020
  6. Specific features of colorectal cancer in patients with metabolic syndrome: a matched case-control analysis of 772 patients vol.403, pp.4, 2018, https://doi.org/10.1007/s00423-018-1677-y
  7. Association between blood pressure and risk of cancer development: a systematic review and meta-analysis of observational studies vol.9, pp.None, 2019, https://doi.org/10.1038/s41598-019-45014-4
  8. Metabolic syndrome and liver-related events: a systematic review and meta-analysis vol.19, pp.1, 2016, https://doi.org/10.1186/s12902-019-0366-3
  9. 대사증후군 성인의 흡연 및 음주 상태가 대장암 발생 위험에 미치는 영향: 전향적 코호트 연구 vol.49, pp.6, 2016, https://doi.org/10.4040/jkan.2019.49.6.713
  10. The Metabolic Syndrome Is a Risk Factor for Breast Cancer: A Systematic Review and Meta-Analysis vol.13, pp.4, 2016, https://doi.org/10.1159/000507554
  11. Association between Abdominal Obesity and Incident Colorectal Cancer: A Nationwide Cohort Study in Korea vol.12, pp.6, 2020, https://doi.org/10.3390/cancers12061368
  12. Metabolic Syndrome and Risk of Lung Cancer: An Analysis of Korean National Health Insurance Corporation Database vol.105, pp.11, 2016, https://doi.org/10.1210/clinem/dgaa596
  13. Metabolic syndrome and the incidence of lung cancer: a meta-analysis of cohort studies vol.12, pp.None, 2020, https://doi.org/10.1186/s13098-020-00598-0
  14. Metabolic syndrome and esophageal cancer risk: a systematic review and meta‑analysis vol.13, pp.None, 2016, https://doi.org/10.1186/s13098-021-00627-6